col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


37 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: Cell Death and Disease
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Sep―13 Text mining method to unravel long COVID’s clinical condition in hospitalized patients Pilar Tavares Veras Florentino, Vinícius de Oliveira Araújo, Henrique Zatti, Caio Vinícius Luis, Célia Regina Santos Cavalcanti, Matheus Henrique Citibaldi de Oliveira, et al. (+12)
2 [GO] 2024―Jun―28 A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug Qianyun Liu, Yuchi Lu, Chenguang Cai, Yanyan Huang, Li Zhou, Yanbin Guan, et al. (+12)
3 [GO] 2024―Apr―11 Research progress of post-acute sequelae after SARS-CoV-2 infection Taiwei Jiao, Yuling Huang, Haiyan Sun, Lina Yang
4 [GO] 2024―Feb―14 Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, Allan Sauvat, Mathilde Roumier, Delphine Cantin, et al. (+34)
5 [GO] 2024―Jan―30 Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo Stefanie M. Bader, James P. Cooney, Reet Bhandari, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, et al. (+6)
6 [GO] 2023―Sep―06 Immune landscape and redox imbalance during neurological disorders in COVID-19 Abhimanyu Thakur, Vartika Sharma, Sera Averbek, Lifan Liang, Nirali Pandya, Gaurav Kumar, et al. (+2)
7 [GO] 2023―Jun―30 SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors Yang Yang, Gaosi Xu
8 [GO] 2023―Apr―29 Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M Elena Poggio, Francesca Vallese, Andreas J. W. Hartel, Travis J. Morgenstern, Scott A. Kanner, Oliver Rauh, et al. (+7)
9 [GO] 2023―Apr―22 Novel insight into the underlying dysregulation mechanisms of immune cell-to-cell communication by analyzing multitissue single-cell atlas of two COVID-19 patients Shijie Qin, Xiaohong Yao, Weiwei Li, Canbiao Wang, Weijun Xu, Zhenhua Gan, et al. (+18)
10 [GO] 2023―Apr―19 Plasma metabolomic characterization of SARS-CoV-2 Omicron infection Xue Li, Yimeng Liu, Guiying Xu, Yi Xie, Ximo Wang, Junping Wu, Huaiyong Chen
11 [GO] 2023―Feb―01 SARS-CoV-2 infection induces persistent adipose tissue damage in aged golden Syrian hamsters Gemma Bogard, Johanna Barthelemy, Aline Hantute-Ghesquier, Valentin Sencio, Patricia Brito-Rodrigues, Karin Séron, et al. (+7)
12 [GO] 2023―Jan―21 Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy Pavlina Spiliopoulou, Helena J. Janse van Rensburg, Lisa Avery, Vathany Kulasingam, Albiruni Razak, Philippe Bedard, et al. (+11)
13 [GO] 2022―Okt―03 Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer Mariana Suaya, Gonzalo Manuel Sánchez, Antonella Vila, Analía Amante, María Cotarelo, Mercedes García Carrillo, Matías Blaustein
14 [GO] 2022―Aug―27 Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients Sonia André, Marne Azarias da Silva, Morgane Picard, Aurélie Alleaume-Buteau, Lucy Kundura, Renaud Cezar, et al. (+21)
15 [GO] 2022―Aug―06 USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING Rebekka Karlowitz, Megan L. Stanifer, Jens Roedig, Geoffroy Andrieux, Denisa Bojkova, Marco Bechtel, et al. (+7)
16 [GO] 2022―Mai―25 Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants Daniela Iaconis, Licia Bordi, Giulia Matusali, Carmine Talarico, Candida Manelfi, Maria Candida Cesta, et al. (+17)
17 [GO] 2022―Mai―14 Sex differences in global metabolomic profiles of COVID-19 patients Rocio Diaz Escarcega, Pedram Honarpisheh, Gabriela Delevati Colpo, Hilda W. Ahnstedt, Lucy Couture, Shivanki Juneja, et al. (+9)
18 [GO] 2022―Mrz―14 Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge Hongwei Li, Xue Li, Qian Wu, Xing Wang, Zhonghua Qin, Yaguo Wang, et al. (+4)
19 [GO] 2021―Okt―29 Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, Simona di Martino, Francesca De Nicola, Frauke Goeman, et al. (+21)
20 [GO] 2021―Aug―12 Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome Francesco Messina, Emanuela Giombini, Chiara Montaldo, Ashish Arunkumar Sharma, Antonio Zoccoli, Rafick-Pierre Sekaly, et al. (+6)
21 [GO] 2021―Aug―05 Low level of plasminogen increases risk for mortality in COVID-19 patients David Della-Morte, Francesca Pacifici, Camillo Ricordi, Renato Massoud, Valentina Rovella, Stefania Proietti, et al. (+5)
22 [GO] 2021―Aug―03 Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia Alessandro Mauriello, Manuel Scimeca, Ivano Amelio, Renato Massoud, Antonio Novelli, Francesca Di Lorenzo, et al. (+9)
23 [GO] 2021―Jul―23 RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes Yuting Meng, Qiong Zhang, Kaihang Wang, Xujun Zhang, Rongwei Yang, Kefan Bi, et al. (+2)
24 [GO] 2021―Mai―25 Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery Kaimin Mao, Qi Tan, Yanling Ma, Sufei Wang, Hua Zhong, Yuhan Liao, et al. (+8)
25 [GO] 2021―Mrz―24 Inhibition of HECT E3 ligases as potential therapy for COVID-19 Giuseppe Novelli, Jing Liu, Michela Biancolella, Tonino Alonzi, Antonio Novelli, J. J. Patten, et al. (+34)
26 [GO] 2021―Mrz―12 Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis Roberta Nardacci, Francesca Colavita, Concetta Castilletti, Daniele Lapa, Giulia Matusali, Silvia Meschi, et al. (+7)
27 [GO] 2021―Mrz―11 Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, Allan Sauvat, Mathilde Roumier, Delphine Cantin, et al. (+34)
28 [GO] 2021―Jan―07 SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype Dario Bongiovanni, Melissa Klug, Olga Lazareva, Simon Weidlich, Marina Biasi, Simona Ursu, et al. (+10)
29 [GO] 2020―Dez―08 A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection Peng Wang, Ronghua Luo, Min Zhang, Yaqing Wang, Tianzhang Song, Tingting Tao, et al. (+7)
30 [GO] 2020―Nov―06 Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients Roberta Angioni, Ricardo Sánchez-Rodríguez, Fabio Munari, Nicole Bertoldi, Diletta Arcidiacono, Silvia Cavinato, et al. (+6)
31 [GO] 2020―Okt―27 Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome Alessandra Sacchi, Germana Grassi, Veronica Bordoni, Patrizia Lorenzini, Eleonora Cimini, Rita Casetti, et al. (+15)
32 [GO] 2020―Sep―24 COVID19: an announced pandemic Sara Platto, Tongtong Xue, Ernesto Carafoli
33 [GO] 2020―Aug―19 On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2 Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, Martina Di Rienzo, Concetta Castilletti, Maria Rosaria Capobianchi, et al. (+5)
34 [GO] 2020―Jul―08 BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic? Abhibhav Sharma, Saurabh Kumar Sharma, Yufang Shi, Enrico Bucci, Ernesto Carafoli, Gerry Melino, et al. (+2)
35 [GO] 2020―Jul―08 Is hydroxychloroquine beneficial for COVID-19 patients? Xing Li, Ying Wang, Patrizia Agostinis, Arnold Rabson, Gerry Melino, Ernesto Carafoli, et al. (+2)
36 [GO] 2020―Jun―08 COVID-19 infection: the China and Italy perspectives Jun Chen, Hongzhou Lu, Gerry Melino, Stefania Boccia, Mauro Piacentini, Walter Ricciardi, et al. (+3)
37 [GO] 2020―Jun―08 The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia Hongbo Shi, Wenjing Wang, Jiming Yin, Yabo Ouyang, Lijun Pang, Yingmei Feng, et al. (+5)
 [1] 

37 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec